Somatostatin
- Generic Name
- Somatostatin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C76H104N18O19S2
- CAS Number
- 38916-34-6
- Unique Ingredient Identifier
- 6E20216Q0L
- Background
Somatostatin, also known as growth hormone-inhibiting hormone, is a naturally-occurring peptide hormone of 14 or 28 amino acid residues that regulates the endocrine system. It is secreted by the D cells of the islets to inhibit the release of insulin and glucagon, and is also generated in the hypothalamus, where it inhibits the release of growth hormone and...
- Indication
For the symptomatic treatment of acute bleeding from esophageal varices. Other treatment options for long-term management of the condition may be considered if necessary, once initial control has been established.
- Associated Conditions
- Acromegaly, Bleeding caused by Gastritis erosive, Diabetic Ketoacidosis, Duodenal ulcer haemorrhage, Fistula of small intestine, Fistula, Biliary, Gastric ulcer haemorrhage, Gastritis haemorrhagic, Oesophageal varices haemorrhage, Pancreatic Fistula, Postoperative Complications caused by Pancreatic Surgery
- Associated Therapies
- Restriction of Secretions
A Trial of Somatostatin With Endoscopic Variceal Ligation (EVL) in Control of Acute Variceal Bleeding
- Conditions
- Interventions
- First Posted Date
- 2010-12-28
- Last Posted Date
- 2010-12-28
- Lead Sponsor
- Govind Ballabh Pant Hospital
- Target Recruit Count
- 61
- Registration Number
- NCT01267669
- Locations
- 🇮🇳
Department of Gastroenterology, G B Pant Hospital, New Delhi, Delhi, India
Identifying the Effect of Somatostatin Treatment in Early Postoperative Simple Small Bowel Obstruction
- Conditions
- Interventions
- First Posted Date
- 2010-03-08
- Last Posted Date
- 2011-08-03
- Lead Sponsor
- Nanjing PLA General Hospital
- Target Recruit Count
- 44
- Registration Number
- NCT01082627
- Locations
- 🇨🇳
Nanjing PLAGH, Nanjing, Jiangsu, China
Peripheral Metabolic Effects of Somatostatin
- Conditions
- Interventions
- First Posted Date
- 2010-02-04
- Last Posted Date
- 2013-01-21
- Lead Sponsor
- University of Aarhus
- Target Recruit Count
- 8
- Registration Number
- NCT01062529
- Locations
- 🇩🇰
Medical department M, Aarhus, Denmark
Efficacy of Administration of Somatostatin in the Prevention of Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis
- Conditions
- Interventions
- First Posted Date
- 2010-02-02
- Last Posted Date
- 2011-06-22
- Target Recruit Count
- 510
- Registration Number
- NCT01060826
- Locations
- 🇪🇸
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
🇪🇸Endoscopy Unit Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2010-01-21
- Last Posted Date
- 2013-12-20
- Lead Sponsor
- Shanghai Jiao Tong University School of Medicine
- Target Recruit Count
- 216
- Registration Number
- NCT01053390
- Locations
- 🇨🇳
Xinhua hospital affiliated shanghai jiaotong, Shanghai, China
Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding
- Conditions
- Interventions
- First Posted Date
- 2009-08-26
- Last Posted Date
- 2018-03-19
- Lead Sponsor
- Korea University
- Target Recruit Count
- 1034
- Registration Number
- NCT00966355
- Locations
- 🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of
Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia Unawareness
- First Posted Date
- 2008-11-19
- Last Posted Date
- 2018-01-18
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 19
- Registration Number
- NCT00793741
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
Measurement of Glucose/Glycogen Metabolism in Humans Using Magnetic Resonance at 4 or 7 Tesla
- First Posted Date
- 2008-11-06
- Last Posted Date
- 2019-12-18
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 10
- Registration Number
- NCT00786825
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
Effect of Elevated Plasma-Free-Fatty-Acids on Renal Hemodynamic Parameters
- Conditions
- First Posted Date
- 2007-02-06
- Last Posted Date
- 2007-02-06
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 9
- Registration Number
- NCT00431665
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.